NASHVILLE, Tenn.–(BUSINESS WIRE)–SurgNet Health Partners, Inc. (SurgNet), a Nashville-based Ambulatory Surgery Center (ASC) development and management company, announced the acquisitions of Executive Ambulatory Surgery Center and Lippy Surgery Center…
Author: Business Wire
RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at Eyecelerator at 2023 American Academy of Ophthalmology (AAO) Annual Meeting
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Oxular Doses First Patients in OXEYE Phase 2 Clinical Trial of Suprachoroidal OXU-001 as a Long-Acting Treatment for Diabetic Macular Edema
OXFORD, United Kingdom & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oxular Limited, a clinical-stage ophthalmic company developing long-lasting treatments for retinal disorders, today announces that it has begun dosing in its OXEYE Phase 2 clinical trial evalu…
Aurion Biotech Announces First Subject Dosed in U.S. Phase 1 / 2 Clinical Trial
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has dosed the first subject in its Phase 1 / 2 U.S. clini…
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) for the following products: FLAREX® (fluorom…
CourtAvenue Earns Top Honors as AdWeek's 2023 #1 Fastest Growing Agency
SAN DIEGO–(BUSINESS WIRE)–AdWeek named CourtAvenue, the leading digital transformation agency, the #1 Fastest Growing Agency in 2023 this week, recognizing its nearly 6000% growth in revenue over the past three years. This prestigious accolade unders…
EMA EHR by ModMed Now Integrates With Weave
LEHI, Utah–(BUSINESS WIRE)–Weave (NYSE: WEAV), a leading all-in-one experience platform for small and medium-sized healthcare businesses, today announced an integration with EMA EHR by ModMed, the #1 dermatology EHR system. This integration combines …
National Vision Puts Pediatric Eye Care in Focus for 2023-2024 Scholarship Program
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., the nation’s second largest optical retailer providing quality, affordable eye care and eyewear, announced today that its annual scholarship program is open for entries, providing eligible optometry …
STAAR Surgical to Report Third Quarter Results on November 1, 2023
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the third quarter ended September …
Warby Parker to Announce Third Quarter 2023 Financial Results on November 8, 2023
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2023, will be released befor…
Montgomery Parks Helps Color Blind Visitors Experience Nature’s Colors with EnChroma Glasses
WHEATON, Md. & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–Montgomery Parks Helps Color Blind Visitors Experience Nature’s Colors with EnChroma Glasses to Enhance Color Accessibility for Guests
Montecito Medical Completes Acquisition of Seven-Building Portfolio in South Carolina
NASHVILLE, Tenn.–(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has completed the acquisition of seven medical office buildings in upstate South Carolina. Concentrated in the Greenville and Clemson mark…
Humana and USAA Expand Relationship to Offer High-Quality, Affordable Medicare Advantage Plans Designed with Veterans in Mind
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana and USAA have expanded their relationship to offer high-quality, affordable Medicare Advantage plans designed with veterans in mind.
STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer® Lens (ICL). The …
Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2023 financial results on Wednesday, Nov. 1, 2023. …
Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope
DEERFIELD, Ill.–(BUSINESS WIRE)–BAXTER LAUNCHES DIGITAL IMAGE CAPTURE CAPABILITY FOR PANOPTIC PLUS OPHTHALMOSCOPE
Heidelberg Engineering Announces FDA Clearance for All-in-One ANTERION Platform
FRANKLIN, Mass.–(BUSINESS WIRE)–Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, announces FDA clearance of its innovative all-in-one ANTERION® platform, designed to transform anterior segment diagnostics a…
BioFuture™ 2023 Wraps Up After Convening Hundreds of High-Profile Attendees and Record Numbers of Investors and Media
NEW YORK–(BUSINESS WIRE)– #biofuture2023–Demy-Colton’s BioFuture™ concluded this week after bringing together hundreds of life sciences luminaries.
VTI gibt positive vorläufige 1-Jahres-Daten aus der klinischen PROTECT-Studie auf der Jahrestagung der American Academy of Optometry bekannt
NEW ORLEANS–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX:VTI), Hersteller der 1-Tages-Kontaktlinsen NaturalVue® Multifocal, präsentierte vorläufige Daten aus der klinischen PROTECT-Studie auf der Jahrestagung der American Academy of Optometry…
VTI annonce des données provisoires positives à un an de l'essai clinique PROTECT lors de la réunion annuelle de l'American Academy of Optometry
NEW ORLEANS–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX : VTI), fabricant des lentilles de contact NaturalVue® Multifocal 1 Day, a présenté les données provisoires de l’essai clinique PROTECT lors de la réunion annuelle de l’American Academy…